Is pazopanib covered by Medicare?

Is pazopanib covered by Medicare?

Is pazopanib covered by Medicare?

Yes. 100% of Medicare prescription drug plans cover this drug.

Is pazopanib a generic drug?

Pazopanib is the generic name for the trade drug Votrient. In some cases, health care professionals may use the trade name votrient when referring to the generic drug name Pazopanib. Drug Type: Pazopanib is a targeted therapy.

Is pazopanib a chemotherapy?

Sometimes it is used to treat some soft tissue sarcomas when they have spread to other parts of the body and you have already had chemotherapy treatment. Pazopanib is a type of treatment called a tyrosine kinase inhibitor (TKI), also known as a cancer growth inhibitor.

How long can you stay on pazopanib?

The median time on pazopanib in these patients was 2.4 years with the longest duration of 3.7 years.

Is votrient covered by Medicare?

Do Medicare prescription drug plans cover Votrient? Yes. 100% of Medicare prescription drug plans cover this drug.

Who is the manufacturer of Votrient?

Development Timeline for Votrient

Date Article
Apr 26, 2012 Approval FDA Approves Votrient for Advanced Soft Tissue Sarcoma
Oct 19, 2009 Approval FDA Approves GlaxoSmithKline’s Votrient for Advanced Renal Cell Cancer
Oct 5, 2009 GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for Votrient

Does pazopanib cause hair loss?

Temporary hair loss and/or change in hair or skin color may occur. Normal hair growth should return after treatment has ended. Many people using this medication have serious side effects and require a dosage reduction or drug discontinuation.

Does Votrient shrink tumors?

Votrient has been shown to slow the growth and spread of renal cell carcinoma and soft tissue sarcoma. (Renal cell carcinoma is a type of kidney cancer. Soft tissue sarcoma is cancer of the soft tissue, such as muscles, tendons, nerves, and blood vessels.) Votrient may also help shrink these types of tumors.

Does Votrient cause hair loss?

Votrient may cause high blood pressure. Temporary hair loss and/or change in hair or skin color may occur. Normal hair growth should return after treatment with Votrient has ended.